Cargando…

Clinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the PALMS study protocol

BACKGROUND: Carpal tunnel syndrome (CTS) is the most common neuropathy of the upper limb and a significant contributor to hand functional impairment and disability. Effective treatment options include conservative and surgical interventions, however it is not possible at present to predict the outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Jerosch-Herold, Christina, Shepstone, Lee, Wilson, Edward CF, Dyer, Tony, Blake, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921988/
https://www.ncbi.nlm.nih.gov/pubmed/24507749
http://dx.doi.org/10.1186/1471-2474-15-35
_version_ 1782303389486415872
author Jerosch-Herold, Christina
Shepstone, Lee
Wilson, Edward CF
Dyer, Tony
Blake, Julian
author_facet Jerosch-Herold, Christina
Shepstone, Lee
Wilson, Edward CF
Dyer, Tony
Blake, Julian
author_sort Jerosch-Herold, Christina
collection PubMed
description BACKGROUND: Carpal tunnel syndrome (CTS) is the most common neuropathy of the upper limb and a significant contributor to hand functional impairment and disability. Effective treatment options include conservative and surgical interventions, however it is not possible at present to predict the outcome of treatment. The primary aim of this study is to identify which baseline clinical factors predict a good outcome from conservative treatment (by injection) or surgery in patients diagnosed with carpal tunnel syndrome. Secondary aims are to describe the clinical course and progression of CTS, and to describe and predict the UK cost of CTS to the individual, National Health Service (NHS) and society over a two year period. METHODS/DESIGN: In this prospective observational cohort study patients presenting with clinical signs and symptoms typical of CTS and in whom the diagnosis is confirmed by nerve conduction studies are invited to participate. Data on putative predictive factors are collected at baseline and follow-up through patient questionnaires and include standardised measures of symptom severity, hand function, psychological and physical health, comorbidity and quality of life. Resource use and cost over the 2 year period such as prescribed medications, NHS and private healthcare contacts are also collected through patient self-report at 6, 12, 18 and 24 months. The primary outcome used to classify treatment success or failures will be a 5-point global assessment of change. Secondary outcomes include changes in clinical symptoms, functioning, psychological health, quality of life and resource use. A multivariable model of factors which predict outcome and cost will be developed. DISCUSSION: This prospective cohort study will provide important data on the clinical course and UK costs of CTS over a two-year period and begin to identify predictive factors for treatment success from conservative and surgical interventions.
format Online
Article
Text
id pubmed-3921988
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39219882014-02-13 Clinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the PALMS study protocol Jerosch-Herold, Christina Shepstone, Lee Wilson, Edward CF Dyer, Tony Blake, Julian BMC Musculoskelet Disord Study Protocol BACKGROUND: Carpal tunnel syndrome (CTS) is the most common neuropathy of the upper limb and a significant contributor to hand functional impairment and disability. Effective treatment options include conservative and surgical interventions, however it is not possible at present to predict the outcome of treatment. The primary aim of this study is to identify which baseline clinical factors predict a good outcome from conservative treatment (by injection) or surgery in patients diagnosed with carpal tunnel syndrome. Secondary aims are to describe the clinical course and progression of CTS, and to describe and predict the UK cost of CTS to the individual, National Health Service (NHS) and society over a two year period. METHODS/DESIGN: In this prospective observational cohort study patients presenting with clinical signs and symptoms typical of CTS and in whom the diagnosis is confirmed by nerve conduction studies are invited to participate. Data on putative predictive factors are collected at baseline and follow-up through patient questionnaires and include standardised measures of symptom severity, hand function, psychological and physical health, comorbidity and quality of life. Resource use and cost over the 2 year period such as prescribed medications, NHS and private healthcare contacts are also collected through patient self-report at 6, 12, 18 and 24 months. The primary outcome used to classify treatment success or failures will be a 5-point global assessment of change. Secondary outcomes include changes in clinical symptoms, functioning, psychological health, quality of life and resource use. A multivariable model of factors which predict outcome and cost will be developed. DISCUSSION: This prospective cohort study will provide important data on the clinical course and UK costs of CTS over a two-year period and begin to identify predictive factors for treatment success from conservative and surgical interventions. BioMed Central 2014-02-07 /pmc/articles/PMC3921988/ /pubmed/24507749 http://dx.doi.org/10.1186/1471-2474-15-35 Text en Copyright © 2014 Jerosch-Herold et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Jerosch-Herold, Christina
Shepstone, Lee
Wilson, Edward CF
Dyer, Tony
Blake, Julian
Clinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the PALMS study protocol
title Clinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the PALMS study protocol
title_full Clinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the PALMS study protocol
title_fullStr Clinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the PALMS study protocol
title_full_unstemmed Clinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the PALMS study protocol
title_short Clinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the PALMS study protocol
title_sort clinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the palms study protocol
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921988/
https://www.ncbi.nlm.nih.gov/pubmed/24507749
http://dx.doi.org/10.1186/1471-2474-15-35
work_keys_str_mv AT jeroschheroldchristina clinicalcoursecostsandpredictivefactorsforresponsetotreatmentincarpaltunnelsyndromethepalmsstudyprotocol
AT shepstonelee clinicalcoursecostsandpredictivefactorsforresponsetotreatmentincarpaltunnelsyndromethepalmsstudyprotocol
AT wilsonedwardcf clinicalcoursecostsandpredictivefactorsforresponsetotreatmentincarpaltunnelsyndromethepalmsstudyprotocol
AT dyertony clinicalcoursecostsandpredictivefactorsforresponsetotreatmentincarpaltunnelsyndromethepalmsstudyprotocol
AT blakejulian clinicalcoursecostsandpredictivefactorsforresponsetotreatmentincarpaltunnelsyndromethepalmsstudyprotocol